In other words, NAT in a CRC patient without recurrence appears to have specific types of gene expression changes that drive tumor growth, and similarly, NAT in a CRC patient with recurrence seem to have other specific types of gene expression changes driving tumor growth. Here, BRD2 is linked to colorectal carcinoma.